RT Book, Section
A1 Honegger, Jonathan
A1 Watson, Joshua R.
A2 Kline, Mark W.
SR Print(0)
ID 1182903554
T1 Human Immunodeficiency Virus Type 1 Infection
T2 Rudolph's Pediatrics, 23e
YR 2018
FD 2018
PB McGraw-Hill Education
PP New York, NY
SN 9781259588594
LK accesspediatrics.mhmedical.com/content.aspx?aid=1182903554
RD 2024/04/24
AB Approximately  2.1  million  children  younger  than  age  15  years  were  living  with  human  immunodeficiency  virus  type  1  (HIV-1)  infection  in  2016,  including  160,000  newly  infected  children.  In  the  same  year,  nearly  120,000  children  died  from  acquired  immunodeficiency  syndrome  (AIDS)-related  illnesses,  and  hundreds  of  thousands  more  children  lost  one  or  both  parents  to  HIV.  HIV  clearly  continues  to  exert  a  devastating  effect  on  global  child  health.  Nevertheless,  expanded  access  to  antiretroviral  therapy  (ART)  is  turning  the  tide  of  this  epidemic.  The  numbers  of  children  newly  infected  with  HIV-1  and  children  dying  of  AIDS-related  illness  in  2016  were  approximately  half  what  they  were  in  2010.  For  many  children  with  access  to  ART,  HIV-1  has  become  a  manageable,  chronic  disease  rather  a  certain  cause  of  early  death.